We observed a significant reduction in tumor-induced osteolysis and osteoclast homing at the tumor-bone interface in mice injected with Cl66 CXCR2 knockdown (Cl66-shCXCR2) cells in comparison with mice injected with Cl66-Control cells (Cl66-Control). Here, CXCR2 is linked to neoplasm.